Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Planning and Dissemination Grant - Institute Community Support

University of Guelph

$10,000.00

Conference on Signalling in Normal and Cancer Cells 2025

EF 2024-25

Résumé
In 2025, the 13th assembly of the Signalling in Normal and Cancer Cells conference will be held in person at the Banff Centre in Banff, Alberta. With a history spanning over 30 years since its inception in 1991, this conference aims to bring together leading Canadian and international scientists, health care workers and stakeholders interested in signal transduction pathways and their involvement in cancer. Specifically, this meeting facilitates research aimed at elucidating the molecular mechanisms that promote the development, survival, and metastasis of cancer cells, and using this information as the basis for diagnostic and therapeutic approaches. From its origins, this conference has witnessed groundbreaking discoveries in cancer research which have ushered in the current era of precision oncology, and it remains a central venue to exchange ideas and accelerate collaborations. The conference features outstanding speakers from all career stages working on various aspects of cell signalling and cancer, spanning fundamental to translational approaches, from across Canada. In addition, several speakers will be from outside Canada, including 2 keynote speakers who are established leaders in the field. Altogether, an attendance of 160-200 scientists is expected, including principal investigators, postdoctoral scholars and graduate students. Early career researchers will be recognized through multiple presentation opportunities and financial support. Notably, many of the principal investigators leading signal transduction research in Canada have participated in this conference, and thus recognize its impact during their training. Altogether, it is anticipated that this popular conference will continue to both highlight and enhance the quality of research on signal transduction and cancer in Canada, capitalizing on our collective momentum in targeted and immune cancer therapy.
Programme
Planning and Dissemination Grant - Institute Community Support
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
508393
Name
Jones Nina
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Planning and Dissemination Grants
Projecttitle
Conference on Signalling in Normal and Cancer Cells 2025
Programtype2
Miscellaneous Programs
Orgnameinp2
University of Guelph
Cihramount2
$10,000
Cihrequipment2
$0
Programname2
Planning and Dissemination Grant - Institute Community Support
Keyworddelim
Cancer; Cell Signaling; Metastasis; Precision Oncology
Abstract
In 2025, the 13th assembly of the Signalling in Normal and Cancer Cells conference will be held in person at the Banff Centre in Banff, Alberta. With a history spanning over 30 years since its inception in 1991, this conference aims to bring together leading Canadian and international scientists, health care workers and stakeholders interested in signal transduction pathways and their involvement in cancer. Specifically, this meeting facilitates research aimed at elucidating the molecular mechanisms that promote the development, survival, and metastasis of cancer cells, and using this information as the basis for diagnostic and therapeutic approaches. From its origins, this conference has witnessed groundbreaking discoveries in cancer research which have ushered in the current era of precision oncology, and it remains a central venue to exchange ideas and accelerate collaborations. The conference features outstanding speakers from all career stages working on various aspects of cell signalling and cancer, spanning fundamental to translational approaches, from across Canada. In addition, several speakers will be from outside Canada, including 2 keynote speakers who are established leaders in the field. Altogether, an attendance of 160-200 scientists is expected, including principal investigators, postdoctoral scholars and graduate students. Early career researchers will be recognized through multiple presentation opportunities and financial support. Notably, many of the principal investigators leading signal transduction research in Canada have participated in this conference, and thus recognize its impact during their training. Altogether, it is anticipated that this popular conference will continue to both highlight and enhance the quality of research on signal transduction and cancer in Canada, capitalizing on our collective momentum in targeted and immune cancer therapy.
Competitiondate
202408
Approvedterm2
1 yr 0 mth
Pinamesdelim
Jones, Nina
Approvedterm
1 an 0 mois
Cihrcontribution2
ICR~ $10,000~ $0~